Financial Shenanigans
The Forensic Verdict
Forensic Risk Score: 12 / 100 — Clean. IMCV is a passively-managed iShares ETF advised by BlackRock Fund Advisors. The operating-company shenanigans taxonomy (revenue timing, expense capitalization, big-bath reserves, non-GAAP gymnastics) is structurally inapplicable: there is no operating P&L, no working-capital cycle, and no management discretion over earnings. NAV is a daily mark of a basket of 292 mid-cap value U.S. equities, the index methodology sits with an independent provider (Morningstar), and reported total returns track the benchmark within a single basis point in four of the last five fiscal years. The only items worth underwriting are ETF-structural: an affiliated-party securities-lending arrangement, BlackRock-affiliated money-market sweep vehicles inside the fund, representative sampling rather than full replication, and a one-time index-methodology shift in March 2021 that contaminates pre/post-2021 performance comparison. None rise to the level of a thesis-changing distortion.
Forensic Risk Score (0–100)
Red Flags
Yellow Flags
Expense Ratio (bps)
FY25 NAV vs Index gap (bps, abs)
Sec-Lending Income / AUM (bps)
In-Kind Redemption Gains / AUM (%)
13-Category Shenanigans Scorecard
The classical Schilit framework was built for operating businesses. For an open-end registered investment company under the 1940 Act with daily NAV strike and SEC-prescribed reporting, the majority of categories are not applicable by construction. The scorecard below records each category, the verdict, and the reason.
Breeding Ground
The conditions that historically precede earnings manipulation — founder/promoter control, weak audit oversight, compensation linked to a fragile metric, related parties dominating the cap table — are absent. This is a registered investment company, not an operating issuer. The relevant breeding-ground concerns instead live one level up the capital stack: the sponsor's governance and the trust's control environment.
The fund-level breeding ground is benign. The three yellow lines are intrinsic to the iShares operating model — they would appear in any iShares fund — and are managed by SEC exemptive orders that govern affiliated lending agents and affiliated cash sweep. There is no founder, no controlling shareholder, no related-party customer, no aggressive guidance culture, no management contract with hidden incentive layers. The unitary 6-basis-point expense ratio means BFA earns the same fee whether the fund grows or shrinks (in dollar terms it benefits from AUM growth, but there is no per-share metric to manipulate).
Earnings Quality
For an ETF, "earnings" is the sum of net investment income (dividend cash less expenses) and net realized/unrealized gain on the portfolio. Both are mechanical: investment income is the dividend cash actually received from underlying issuers, and realized/unrealized gain is the daily mark-to-market of a publicly priced equity basket. There is no judgment area where management can stretch.
The diagnostic that matters is whether reported NAV total return matches the underlying index — because that is the only real "earnings" claim BlackRock makes about IMCV.
Test 1 — Tracking difference (fund vs benchmark)
The fund has tracked within 15 basis points in every observed calendar year and within 3 basis points in three of the last four. On a 6-bp expense ratio, the tracking difference should run roughly minus 6 bps per year — and it does. Securities lending income (~1.2 bps) partially offsets fee drag. There is no evidence of "tracking error smoothing" or quarter-end window-dressing of marks: NAV is struck against closing prices on regulated exchanges.
Test 2 — Expense ratio stability
The FY2021 reading of 27 bps is not a fee hike followed by a cut — it reflects the fund's repositioning around March 2021, when iShares re-licensed the index from the legacy Morningstar US Mid Value series to the Broad Value series and concurrently re-priced the management fee. Since FY2022 the headline has been 6 bps with zero variance. This is a clean disclosure.
Test 3 — Income mix and the role of in-kind redemptions
The single line that warrants explanation is realized gain on in-kind redemptions of $28.4M — roughly 4.4% of AUM. ETFs satisfy creations and redemptions in baskets of underlying securities rather than in cash, and IRC §852(b)(6) treats the resulting gain as non-taxable at the fund level. The gain shows up in the Statement of Operations, then is reclassified out of accumulated realized gain into paid-in capital at year end. This is the central tax-efficiency feature of every ETF, fully disclosed in Note 2 and on the face of the financial statements. It is not a forensic concern — it is a regulatory feature — but it explains why an ETF can post realized gains larger than its distribution and never trigger a capital-gains distribution to holders.
Cash Flow Quality
A 1940-Act registered fund does not file a Statement of Cash Flows in the operating-company sense. The ETF analog is the Statement of Changes in Net Assets, which decomposes the year-on-year change in AUM into (i) results from investment operations, (ii) distributions to shareholders, and (iii) capital share transactions (creations minus redemptions). The forensic question is whether AUM growth is being flattered by mechanical creations rather than performance.
Sources of FY2025 AUM growth
AUM grew $45.2M in FY2025. Investment operations contributed $33.1M and net creations contributed $27.8M, partially offset by $15.8M of distributions. The ratio of creations to performance is ~84%, meaning roughly half of AUM growth is real demand and half is portfolio appreciation. There is no "lifeline" effect — the fund did not need creations to mask weak underlying returns; the underlying performance (5.39% NAV total return) was nearly identical to the benchmark.
Distribution discipline
Distributions track net investment income tightly. Across the five-year window the cumulative distribution-to-NII ratio is essentially 1.0 — the fund pays out roughly what it earns from dividends. The slight overshoot in FY2025 ($1.86 distributed vs $1.76 NII per share) reflects regulated-investment-company tax distribution requirements and small short-term gain pass-through; it is not a sign of return-of-capital distortion.
Securities lending economics
Lending program is small and conservatively run: only 1.4% of the fund is on loan at year-end, against 102% cash collateral. The economic significance to shareholders is minor — sec-lending income added roughly 1.2 bps to FY25 returns versus the 6 bp expense drag. The yellow flag is procedural, not magnitude-related: the lending agent is a BlackRock affiliate and the cash collateral is reinvested into a BlackRock-affiliated money-market vehicle. Both arrangements operate under SEC exemptive relief and the income is reported "net" of the agent fee in the Statement of Operations.
Metric Hygiene
Where operating companies invent non-GAAP earnings, ETFs lean on three "metrics" that warrant scrutiny: total return vs benchmark, premium/discount to NAV, and the consistency of the benchmark itself.
NAV and market-price returns sit on top of each other across the five-year window — the largest single-year gap is 17 basis points (CY2025, in shareholders' favor). This is a clean signal that secondary-market liquidity has been adequate and that AP arbitrage is functioning. There is no premium-to-NAV creep that would suggest stress in the creation/redemption mechanism.
The single yellow line in the metric scorecard is the 2021 benchmark switch. The fund renamed and re-licensed its tracking index — and the prospectus note honestly splices the old Mid Value Index history with the new Mid Cap Broad Value Index history when reporting "since-inception" returns. A reader who does not notice the footnote will treat the long-run record as one continuous series; in reality the underlying definition changed. This is disclosure hygiene, not deceit, but it matters for any backtest that relies on pre-2021 IMCV NAV to study mid-cap value beta.
What to Underwrite Next
The accounting risk on IMCV is a footnote, not a thesis breaker. Position-sizing should be governed by mid-cap value factor exposure and the 6 bp expense ratio, not by a forensic discount. There are, however, four specific items worth monitoring before underwriting a meaningful allocation.
What would change the grade
- Downgrade to Watch (21–40): auditor change without explanation; persistent premium/discount above 50 bps; a sec-lending arrangement change that materially raises affiliated-party take; an index-methodology change that meaningfully alters factor exposure without parallel disclosure.
- Downgrade to Elevated (41–60): a restated N-CSR; an SEC exam finding against iShares Trust on the IMCV series; failure to make required IRC §852(b)(6) reclassification.
- Upgrade to Clean-clean (under 10): publication of a quarterly premium/discount distribution showing zero stress events over a multi-year window, plus a sec-lending arrangement amendment moving income split toward 80/20 fund/agent.
Bottom line
IMCV's accounting risk is best treated as a footnote in an investment memo, not a valuation haircut, position-sizing limiter, or thesis breaker. The reported 5-year NAV total return is what shareholders actually earned, the 6 bp expense ratio is what they actually paid, and the gap to benchmark is within fee in every observed year. The forensic exposure that does exist — affiliated lending agent, BlackRock cash sweep, in-kind redemption gain reclassification, 2021 benchmark splice — is structural, fully disclosed, and identical across the iShares fund family. An institutional allocator should make this decision on factor exposure, AUM resilience, and trading liquidity. The accounting will not be the reason this position works or fails.